Search

everythinglearnresearchcommunity

for

Search:↓

Certain HSD3B1 gene types are linked to worse prostate cancer outcomes and affect treatment response and other health conditions.

Hormonal treatment is effective for women with acne not helped by usual treatments, especially if they have hormonal imbalances.

Men's age, urinary symptoms, and heart health risks create different types of erectile dysfunction.

Dutasteride may help shrink prostate cancer tumors.

Heredity and hormones cause common hair loss, and topical minoxidil is the first recommended treatment.

Early-onset baldness is linked to genetics, lifestyle, and can indicate higher risk for heart and metabolic diseases, and affects mental health.

New treatments for male hypogonadism are effective and should be personalized.

Athletes use steroids to enhance performance despite health risks and legal issues, and education on their dangers is needed.

Plant steroid hormones show growth, health, and medicinal benefits in various organisms, including potential for treating diseases.

New androgen receptor modulators show promise for treating diseases like prostate cancer and muscle wasting.

The document concludes that hormonal biomarkers are key for diagnosing hyperandrogenemia in women and hypogonadism in men.

No definitive link between finasteride and male breast cancer, but further research is needed.

Finasteride may cause breast enlargement, low testosterone a risk factor.

The length of the CAG repeat in the androgen receptor gene affects the risk and progression of prostate cancer, BPH, infertility, and undermasculinized genitalia.

Hormones affect prostate health and disease, with certain hormone imbalances linked to prostate cancer and benign prostatic hyperplasia.

Finasteride reduces prostate size and serum levels, helping manage benign prostatic hyperplasia, without affecting prostate cancer detection. Regular monitoring is needed for users.

Bioengineered nanoparticles can effectively treat hair loss by targeting specific enzymes and receptors.

A new drug, dutasteride, is at least as effective as the older drug, finasteride, for treating enlarged prostate and may have additional uses.

Dutasteride can reduce night-time urination but it doesn't improve sleep quality.

Endurance exercise may help BPH by lowering hormones and inflammation.

Most legal cases about 5α-reductase inhibitors, drugs for hair loss and prostate issues, complain about side effects and delayed cancer diagnosis, with most lawsuits settled out of court.

Eosinophilic cystitis is often misdiagnosed, but accurate diagnosis and treatment improve outcomes.

Castration significantly reduces prostate size and BPH symptoms.

Androgenetic alopecia is linked to heart disease, metabolic issues, and mental health problems.

The true incidence of post-Finasteride syndrome is unclear, and more research is needed.

Urologists should monitor mental health in patients taking finasteride due to potential links to suicidal thoughts, adjusting dosage or stopping use if necessary. More research is needed to confirm if finasteride causes these thoughts.

Hormonal interactions, especially involving DHT and estrogen, play a key role in BPH development and treatment.

Dihydrotestosterone (DHT) mainly affects nearby cells, doesn't significantly change prostate hormonal environment or cancer risk, and doesn't play a main role in causing hair loss or acne. More research is needed on its effects on heart health, sexual function, and bone health.

New liposome treatment successfully delivers CRISPR to deactivate a key enzyme in androgen-related disorders.

Dihydrotestosterone and 5α-Reductase play a role in hair loss and prostate health, and finasteride can increase hair growth in men without affecting sperm production, but it doesn't work for postmenopausal women with hair loss.